A reinforcement learning approach for individualizing erythropoietin dosages in hemodialysis patients
暂无分享,去创建一个
Jürgen Schmidhuber | José David Martín-Guerrero | Emilio Soria-Olivas | Faustino J. Gomez | N. Víctor Jiménez | Mónica Climente-Martí | J. Schmidhuber | F. Gomez | E. Soria-Olivas | J. Martín-Guerrero | N. V. Jiménez | M. Climente-Martí | J. Martín-Guerrero | N. Jiménez-Torres
[1] A. Barto,et al. Improved Temporal Difference Methods with Linear Function Approximation , 2004 .
[2] John N. Tsitsiklis,et al. Neuro-Dynamic Programming , 1996, Encyclopedia of Machine Learning.
[3] Richard S. Sutton,et al. Reinforcement Learning: An Introduction , 1998, IEEE Trans. Neural Networks.
[4] R. Bellazzi. Drug delivery optimization through Bayesian networks: an application to erythropoietin therapy in uremic anemia. , 1993, Computers and biomedical research, an international journal.
[5] Antonio J. Serrano,et al. Dosage individualization of erythropoietin using a profile-dependent support vector regression , 2003, IEEE Transactions on Biomedical Engineering.
[6] Antonio J. Serrano,et al. Use of neural networks for dosage individualisation of erythropoietin in patients with secondary anemia to chronic renal failure , 2003, Comput. Biol. Medicine.
[7] P. Werbos,et al. Beyond Regression : "New Tools for Prediction and Analysis in the Behavioral Sciences , 1974 .
[8] E. S. Olivas,et al. Use of neural networks for dosage individualisation of erythropoietin in patients with secondary anemia to chronic renal failure. , 2003, Computers in biology and medicine.
[9] David P Steensma,et al. Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Jacek M. Zurada,et al. Individualization of pharmacological anemia management using reinforcement learning , 2005, Neural Networks.
[11] R. Bellazzi,et al. Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness? , 1994, Haematologica.